Nerve regeneration
Ramon-Cueto A. Olfactory ensheathing glia
transplantation into the injured spinal cord. Prog
Brain Res. 2000;128:265-72. Review. No abstract available.
Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J.
Functional recovery of paraplegic rats and motor axon
regeneration in their spinal cords by olfactory ensheathing glia. Neuron. 2000 Feb;25(2):425-35.
Ramon-Cueto A, Avila J. Two modes of
microtubule-associated protein 1B phosphorylation are
differentially regulated during peripheral nerve regeneration. Brain Res. 1999 Jan 9;815(2):213-26.
Ramon-Cueto A, Avila J. Olfactory ensheathing
glia: properties and function.
Brain Res Bull. 1998 Jun;46(3):175-87. Review.
Ramon-Cueto A, Valverde F. Olfactory bulb
ensheathing glia: a unique cell type with axonal growth-promoting
properties. Glia. 1995 Jul;14(3):163-73. Review.
Ramon-Cueto A, Nieto-Sampedro M. Regeneration
into the spinal cord of transected dorsal root axons is promoted
by ensheathing glia transplants. Exp Neurol. 1994
Jun;127(2):232-44.
Stem Cell Research
Abuljadayel IS. Induction
of stem cell-like plasticity in mononuclear cells derived from
unmobilised adult human peripheral blood. Curr Med
Res Opin. 2003;19(5):355-75.
Abuljadayel IS, Afghan RK, McCaffrey TA, Lundergan C,
Hawley TS, Hawley RG, Dhoot GJ. SCID repopulating
cells derived from unmobilised adult human peripheral blood.
Curr Med Res Opin. 2004 Jan;20(1):87-100.
Ecogenetics
Costa LG. The emerging field of ecogenetics. Neurotoxicology.
2000 Feb-Apr;21(1-2):85-9. Review
Rupa DS, Rita P, Reddy PP, Reddi OS.
Screening of chromosomal aberrations and sister chromatid
exchanges in peripheral lymphocytes of vegetable garden workers. Hum Toxicol. 1988 Jul;7(4):333-6.
Kelsey KT, Smith TJ, Hammond SK, Letz R, Little JB .
Sister-chromatid exchanges in lymphocytes from styrene-exposed
boat builders. Mutat Res. 1990 Jun;241(2):215-21.
Horvath E, Pongracz K, Rappaport S, Bodell WJ.
32P-post-labeling detection of DNA adducts in mononuclear cells
of workers occupationally exposed to styrene.
Carcinogenesis. 1994 Jul;15(7):1309-15.
Schempp W, Krone W. Deficiency of arginine
and lysine causes increase in the frequency of sister chromatid
exchanges. Hum Genet. 1979 Oct 2;51(3):315-8.
Czene K, Osterman-Golkar S, Yun X, Li G, Zhao F, Perez
HL, Li M, Natarajan AT, Segerback D. Analysis of DNA
and hemoglobin adducts and sister chromatid exchanges in a human
population occupationally exposed to propylene oxide: a pilot
study. Cancer Epidemiol Biomarkers Prev. 2002
Mar;11(3):315-8.
Kelsey KT, Wiencke JK, Eisen EA, Lynch DW, Lewis TR,
Little JB. Persistently elevated sister chromatid
exchanges in ethylene oxide-exposed primates: the role of a
subpopulation of high frequency cells.
Cancer Res. 1988 Sep 1;48(17):5045-50.
Sarto F, Clonfero E, Bartolucci GB, Franceschi C,
Chiricolo M, Levis AG. Sister chromatid exchanges and
DNA repair capability in sanitary workers exposed to ethylene
oxide: evaluation of the dose-effect relationship.Am
J Ind Med. 1987;12(5):625-37.
Shaham J, Bomstein Y, Melzer A, Ribak J.
DNA-Protein Crosslinks and Sister Chromatid Exchanges as
Biomarkers of Exposure to Formaldehyde. Int J
Occup Environ Health. 1997 Apr;3(2):95-104.
Sinha AK, Linscombe VA, Gollapudi BB, Jersey GC, Park
CN. Analysis of sister chromatid exchanges in
lymphocytes cultured from 71 healthy men. Cell
Biol Toxicol. 1985 Oct;1(4):333-42.
Kudriashova OV, Zhloba AA. [Regularities in
formation of sister chromatid exchanges (SCE) in three
generations after irradiation] Tsitologiia.
2000;42(4):392-8. Russian.
Haglund U, Lundberg I, Zech L. Chromosome
aberrations and sister chromatid exchanges in Swedish paint
industry workers. Scand J Work Environ Health.
1980 Dec;6(4):291-8.
Andersson HC, Tranberg EA, Uggla AH, Zetterberg G.
Chromosomal aberrations and sister-chromatid exchanges in
lymphocytes of men occupationally exposed to styrene in a
plastic-boat factory. Mutat Res. 1980
Dec;73(2):387-401.
Lerda D, Rizzi R. Cytogenetic study of
persons occupationally exposed to ethylene oxide.
Mutat Res. 1992 Jan;281(1):31-7.
Donmez H, Dursun N, Ozkul Y, Demirtas H.
Increased sister chromatid exchanges in workers exposed to
occupational lead and zinc. Biol Trace Elem Res.
1998 Jan;61(1):105-9
Vitamins, minerals, herbs and anti oxidants in therapy
von Moltke LL, Weemhoff JL, Bedir E, Khan IA, Harmatz
JS, Goldman P, Greenblatt DJ. Inhibition of human
cytochromes P450 by components of Ginkgo biloba.
J Pharm Pharmacol. 2004 Aug;56(8):1039-44.
Slade N, Storga-Tomic D, Birkmayer GD, Pavelic K,
Pavelic J. Effect of extracellular NADH on human tumor
cell proliferation.
Anticancer Res. 1999 Nov-Dec;19(6B):5355-60.
Forsyth LM, Preuss HG, MacDowell AL, Chiazze L Jr,
Birkmayer GD, Bellanti JA. Therapeutic effects of oral
NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999 Feb;82(2):185-91.
Birkmayer W, Birkmayer GJ.
Nicotinamidadenindinucleotide (NADH): the new approach in the
therapy of Parkinson's disease.
Ann Clin Lab Sci. 1989 Jan-Feb;19(1):38-43.
Birkmayer GJ, Birkmayer W. Stimulation of
endogenous L-dopa biosynthesis--a new principle for the therapy
of Parkinson's disease. The clinical effect of nicotinamide
adenine dinucleotide (NADH) and nicotinamide adenine
dinucleotidephosphate (NADPH). Acta Neurol Scand
Suppl. 1989;126:183-7.
Birkmayer W, Birkmayer GJ, Vrecko K, Mlekusch W, Paletta
B, Ott E. The coenzyme nicotinamide adenine
dinucleotide (NADH) improves the disability of parkinsonian
patients. J Neural Transm Park Dis Dement Sect.
1989;1(4):297-302.
National Parkinson foundation - good general site for vitamins
and Parkinson's
Circuminoids - research
Rinaldi AL, Morse MA, Fields HW, Rothas DA, Pei P,
Rodrigo KA, Renner RJ, Mallery SR. Curcumin activates
the aryl hydrocarbon receptor yet significantly inhibits
(-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral
squamous cell carcinoma cells and oral mucosa.
Cancer Res. 2002 Oct 1;62(19):5451-6.
Rinaldi AL, Morse MA, Fields HW, Rothas DA, Pei P,
Rodrigo KA, Renner RJ, Mallery SR. Curcumin
activates the aryl hydrocarbon receptor yet significantly
inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol
bioactivation in oral squamous cell carcinoma cells and oral
mucosa. Cancer Res. 2002 Oct 1;62(19):5451-6.
Latchoumycandane C, Mathur PP. Effects of
vitamin E on reactive oxygen species-mediated
2,3,7,8-tetrachlorodi-benzo-p-dioxin toxicity in rat testis. J Appl Toxicol. 2002 Sep-Oct;22(5):345-51.
Shon YH, Park IK, Moon IS, Chang HW, Park IK, Nam KS.
Effect of chitosan oligosaccharide on
2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in
mice. Biol Pharm Bull. 2002 Sep;25(9):1161-4.
Vojdani A, Bazargan M, Vojdani E, Wright J.
New evidence for antioxidant properties of vitamin C.
Cancer Detect Prev. 2000;24(6):508-23.
Kurl S, Tuomainen TP, Laukkanen JA, Nyyssonen K, Lakka
T, Sivenius J, Salonen JT. Plasma vitamin C modifies
the association between hypertension and risk of stroke. Stroke. 2002 Jun;33(6):1568-73.
Heuser G, Vojdani A. Enhancement of natural
killer cell activity and T and B cell function by buffered
vitamin C in patients exposed to toxic chemicals: the role of
protein kinase-C. Immunopharmacol Immunotoxicol.
1997 Aug;19(3):291-312.
Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ.
Oxygen free radical scavenging abilities of vitamins C and E, and
a grape seed proanthocyanidin extract in vitro.Res
Commun Mol Pathol Pharmacol. 1997 Feb;95(2):179-89.
Bagchi D, Bagchi M, Stohs SJ. Comparative in
vitro oxygen radical scavenging ability of zinc methionine and
selected zinc salts and antioxidants. Gen
Pharmacol. 1997 Jan;28(1):85-91.
Bagchi D, Bagchi M, Stohs SJ, Ray SD, Sen CK, Preuss HG.
Cellular Protection with Proanthocyanidins Derived from Grape
Seeds. Ann N Y Acad Sci. 2002 May;957:260-270.
Preuss HG, Bagchi D, Bagchi M. Protective
Effects of a Novel Niacin-Bound Chromium Complex and a Grape Seed
Proanthocyanidin Extract on Advancing Age and Various Aspects of
Syndrome X.
Ann N Y Acad Sci. 2002 May;957:250-259.
Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S.
Oxygen, Oxidants, and Antioxidants in Wound Healing: An Emerging
Paradigm. Ann N Y Acad Sci. 2002 May;957:239-249.
Spence JD, Howard VJ, Chambless LE, Malinow MR,
Pettigrew LC, Stampfer M, Toole JF. Vitamin
Intervention for Stroke Prevention (VISP) trial: rationale and
design. Neuroepidemiology. 2001 Feb;20(1):16-25.
Rath M, Pauling L. Hypothesis: lipoprotein(a)
is a surrogate for ascorbate. Proc Natl Acad Sci U
S A. 1990 Aug;87(16):6204-7.
Schoenthaler SJ, Bier ID. The effect of
vitamin-mineral supplementation on juvenile delinquency among
American schoolchildren: a randomized, double-blind
placebo-controlled trial. J Altern Complement Med.
2000 Feb;6(1):7-17.
Spence JD, Howard VJ, Chambless LE, Malinow MR,
Pettigrew LC, Stampfer M, Toole JF Vitamin
Intervention for Stroke Prevention (VISP) trial: rationale and
design. Neuroepidemiology. 2001 Feb;20(1):16-25.
Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ,
Delport R, Potgieter HC. Vitamin requirements for the
treatment of hyperhomocysteinemia in humans. J
Nutr. 1994 Oct;124(10):1927-33.
Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ.
Vitamin B-12, vitamin B-6, and folate nutritional status in men
with hyperhomocysteinemia. Am J Clin Nutr. 1993
Jan;57(1):47-53.
Malinow MR. Homocyst(e)ine, vitamins and
genetic interactions in vascular disease. Can J
Cardiol. 1999 Apr;15 Suppl B:31B-34B.
Ubbink JB. Vitamin nutrition status and
homocysteine: an atherogenic risk factor. Nutr
Rev. 1994 Nov;52(11):383-7. Review.
Herbert V. Vitamin B-12 and folic acid
supplementation. Am J Clin Nutr. 1997
Dec;66(6):1479-80. No abstract available.
Lobo A, Naso A, Arheart K, Kruger WD, Abou-Ghazala T,
Alsous F, Nahlawi M, Gupta A, Moustapha A, van Lente F, Jacobsen
DW, Robinson K. Reduction of homocysteine levels in
coronary artery disease by low-dose folic acid combined with
vitamins B6 and B12. Am J Cardiol. 1999 Mar
15;83(6):821-5.
Warren CJ. What is homocysteine? Am J Nurs. 1999 Oct;99(10):39-41. Review. No abstract
available.
Clarke R, Armitage J. Vitamin supplements and
cardiovascular risk: review of the randomized trials of
homocysteine-lowering vitamin supplements. Semin
Thromb Hemost. 2000;26(3):341-8. Review.
Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH,
Lindenbaum J. Effects of vitamin B12, folate, and
vitamin B6 supplements in elderly people with normal serum
vitamin concentrations. Lancet. 1995 Jul
8;346(8967):85-9.
Bronstrup A, Hages M, Prinz-Langenohl R, Pietrzik K.
Effects of folic acid and combinations of folic acid and vitamin
B-12 on plasma homocysteine concentrations in healthy, young
women. Am J Clin Nutr. 1998 Nov;68(5):1104-10.
Borner E. [Hepatitis course with and without
vitamin B12--folic acid therapy] Med Welt. 1970
Jun 13;24:1107-12. German. No abstract available.
Dierkes J, Domrose U, Bosselmann KP, Neumann KH, Luley
C. Homocysteine lowering effect of different
multivitamin preparations in patients with end-stage renal
disease. J Ren Nutr. 2001 Apr;11(2):67-72.
Dierkes J, Westphal S, Kunstmann S, Banditt P, Lossner
A, Luley C. Vitamin supplementation can markedly
reduce the homocysteine elevation induced by fenofibrate. Atherosclerosis. 2001 Sep;158(1):161-4.
Hockly E, Brown MJ. Homocysteine, vitamins
and sex. Eur Heart J. 1999 Sep;20(17):1222-3. No
abstract available.
Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH,
Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC.
Homocysteine metabolism and risk of myocardial infarction:
relation with vitamins B6, B12, and folate. Am J
Epidemiol. 1996 May 1;143(9):845-59.
Whanger PD.Selenocompounds in plants and
animals and their biological significance. J Am
Coll Nutr. 2002 Jun;21(3):223-32.
Amantana A, Santana-Rios G, Butler JA, Xu M, Whanger PD,
Dashwood RH. Antimutagenic activity of
selenium-enriched green tea toward the heterocyclic amine
2-amino-3-methylimidazo[4,5-f]quinoline.
Biol Trace Elem Res. 2002 May;86(2):177-91.
Whanger PD. Selenium and the brain: a review. Nutr Neurosci. 2001;4(2):81-97. Review.
Finley JW, Ip C, Lisk DJ, Davis CD, Hintze KJ, Whanger
PD. Cancer-protective properties of high-selenium
broccoli. J Agric Food Chem. 2001
May;49(5):2679-83.
Whanger PD. Selenoprotein W: a review. Cell Mol Life Sci. 2000 Dec;57(13-14):1846-52. Review.
Moore MA, Wandera RC, Xia Y, Du S, Butler JA, Whanger
PD. Selenium supplementation of Chinese women with
habitually low selenium intake increases plasma selenium, plasma
glutathione peroxidase activity, and milk selenium, but not milk
glutathione peroxidase activity(1). J Nutr
Biochem. 2000 Jun 1;11(6):341-347.
Janghorbani M, Xia Y, Ha P, Whanger PD, Butler JA,
Olesik JW, Daniels L. Metabolism of selenite in men
with widely varying selenium status. J Am Coll
Nutr. 1999 Oct;18(5):462-9.
Ueda Y, Whanger PD, Forsberg NE. The effects
of selenium deficiency on differentiation, degradation, and cell
lysis of L8 rat skeletal muscle cells. Biol Trace
Elem Res. 1999 Jul;69(1):1-13
Salonen JT, Alfthan G, Huttunen JK, Puska P
Association between serum selenium and the risk of cancer.
Am J Epidemiol. 1984 Sep;120(3):342-9.
Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr,
Slate EH, Fischbach LA, Marshall JR, Clark LC.
Baseline characteristics and the effect of selenium
supplementation on cancer incidence in a randomized clinical
trial: a summary report of the nutritional prevention of cancer
trial. Cancer Epidemiol Biomarkers Prev. 2002
Jul;11(7):630-9.
Combs GF Jr, Clark LC, Turnbull BW. An
analysis of cancer prevention by selenium.
Biofactors. 2001;14(1-4):153-9. Review.
Nelson MA, Porterfield BW, Jacobs ET, Clark LC.
Selenium and prostate cancer prevention.
Semin Urol Oncol. 1999 May;17(2):91-6. Review.
Clark LC, Jacobs ET. Environmental selenium
and cancer: risk or protection?
Cancer Epidemiol Biomarkers Prev. 1998
Oct;7(10):847-8; discussion 851-2. Review. No abstract available.
Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbull BW,
Slate EH, Witherington R, Herlong JH, Janosko E, Carpenter D,
Borosso C, Falk S, Rounder J. Decreased incidence of
prostate cancer with selenium supplementation: results of a
double-blind cancer prevention trial.
Br J Urol. 1998 May;81(5):730-4.
Combs GF Jr, Clark LC, Turnbull BW. Reduction
of cancer mortality and incidence by selenium supplementation. Med Klin. 1997 Sep 15;92 Suppl 3:42-5.
Combs GF Jr, Clark LC, Turnbull BW. Reduction
of cancer risk with an oral supplement of selenium.
Biomed Environ Sci. 1997 Sep;10(2-3):227-34.
Redman C, Xu MJ, Peng YM, Scott JA, Payne C, Clark LC,
Nelson MA. Involvement of polyamines in
selenomethionine induced apoptosis and mitotic alterations in
human tumor cells.
Carcinogenesis. 1997 Jun;18(6):1195-202.
Co-Enzyme Q10
Langsjoen PH, Langsjoen AM. Overview
of the use of CoQ10 in cardiovascular disease.
Biofactors. 1999;9(2-4):273-84. Review.
Langsjoen PH, Langsjoen A, Willis R, Folkers K.
Treatment of hypertrophic cardiomyopathy with coenzyme Q10.
Mol Aspects Med. 1997;18 Suppl:S145-51.
Langsjoen P, Langsjoen P, Willis R, Folkers K.
Treatment of essential hypertension with coenzyme Q10.
Mol Aspects Med. 1994;15 Suppl:S265-72.
Langsjoen H, Langsjoen P, Langsjoen P, Willis R, Folkers
K. Usefulness of coenzyme Q10 in clinical cardiology:
a long-term study. Mol Aspects Med. 1994;15
Suppl:s165-75.
Langsjoen PH, Langsjoen PH, Folkers K.
Isolated diastolic dysfunction of the myocardium and its response
to CoQ10 treatment. Clin Investig. 1993;71(8
Suppl):S140-4.
Folkers K, Langsjoen P, Langsjoen PH. Therapy
with coenzyme Q10 of patients in heart failure who are eligible
or ineligible for a transplant. Biochem Biophys
Res Commun. 1992 Jan 15;182(1):247-53.
Folkers K, Hanioka T, Xia LJ, McRee JT Jr, Langsjoen P.
Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary
subjects and relevance to patients having the AIDS related
complex.
Biochem Biophys Res Commun. 1991 Apr
30;176(2):786-91.
Folkers K, Langsjoen P, Willis R, Richardson P, Xia LJ,
Ye CQ, Tamagawa H. Lovastatin decreases coenzyme Q
levels in humans. Proc Natl Acad Sci U S A. 1990
Nov;87(22):8931-4.
Langsjoen PH, Langsjoen PH, Folkers K. A
six-year clinical study of therapy of cardiomyopathy with
coenzyme Q10.
Int J Tissue React. 1990;12(3):169-71.
Magnesium
Gordin A, Goldenberg D, Golz A, Netzer A, Joachims HZ.
Magnesium: a new therapy for idiopathic sudden sensorineural
hearing loss. Otol Neurotol. 2002
Jul;23(4):447-51.
Bigal ME, Bordini CA, Speciali JG.[Efficacy
of three drugs in the treatment of migrainous aura: a randomized,
placebo-controlled study] Arq Neuropsiquiatr. 2002
Jun;60(2-B):406-9. Portuguese.
Bigal ME, Bordini CA, Tepper SJ, Speciali JG.
Intravenous magnesium sulphate in the acute treatment of migraine
without aura and migraine with aura. A randomized, double-blind,
placebo-controlled study. Cephalalgia. 2002
Jun;22(5):345-53.
Lin JY, Chung SY, Lin MC, Cheng FC. Effects
of magnesium sulfate on energy metabolites and glutamate in the
cortex during focal cerebral ischemia and reperfusion in the
gerbil monitored by a dual-probe microdialysis technique. Life Sci. 2002 Jul 5;71(7):803-11.
Malcova R, Gryndler M, Vosatka M. Magnesium ions alleviate the negative effect of
manganese on Glomus claroideum BEG23. Mycorrhiza.
2002 Jun;12(3):125-9.
Attygalle D, Rodrigo N. Magnesium
as first line therapy in the management of tetanus: a prospective
study of 40 patients.
Anaesthesia. 2002 Aug;57(8):811-7.
Silverman RA, Osborn H, Runge J, Gallagher EJ, Chiang W,
Feldman J, Gaeta T, Freeman K, Levin B, Mancherje N, Scharf S. IV magnesium sulfate in the treatment of acute
severe asthma: a multicenter randomized controlled trial. Chest. 2002 Aug;122(2):489-97.
Guillain Barre Syndrome/pesticides
Gagandeep, Avasthi G. PAM responsive Gullian
Barre like syndrome with low serum cholinesterase.
J Assoc Physicians India. 1998 Feb;46(2):244-5. No
abstract available.
Altenkirch H, Hopmann D, Brockmeier B, Walter G
Neurological investigations in 23 cases of pyrethroid
intoxication reported to the German Federal Health Office. Neurotoxicology. 1996 Fall-Winter;17(3-4):645-51.
Zhang Z, Zhang X, Wang J, Min B, Tang X. [Risk factors for Guillain-Barre syndrome in
northern China: a case-control study] Zhongguo Yi
Xue Ke Xue Yuan Xue Bao. 1995 Aug;17(4):291-5. Chinese.
Hart DE, Rojas LA, Rosario JA, Recalde H, Roman GC.
Childhood Guillain-Barre syndrome in Paraguay, 1990 to 1991. Ann Neurol. 1994 Dec;36(6):859-63.
Zhang C. [The report of
organophosphorus pesticides cause delayed nervous system diseases
(143 cases)]
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1991
Dec;24(6):336-8, 383. Chinese.
Mishra VN, Raman PG. Guillain Barre syndrome
as a sequela of organophosphorus poisoning.
J Assoc Physicians India. 1988 May;36(5):347. No
abstract available.
Fisher JR. Guillain-Barre syndrome following
organophosphate poisoning. JAMA. 1977 Oct
31;238(18):1950-1. No abstract available.
Menieres Disease
Derebery MJ. Prevalence of heat shock protein
in patients with Meniere's disease and allergy.
Otolaryngol Head Neck Surg. 2002
Jun;126(6):677-82.
Rauch SD, Zurakowski D, Bloch DB, Bloch KJ.
Anti-heat shock protein 70 antibodies in Meniere's disease.
Laryngoscope. 2000 Sep;110(9):1516-21.
Derebery MJ, Berliner KI. Prevalence of
allergy in Meniere's disease. Otolaryngol Head
Neck Surg. 2000 Jul;123(1 Pt 1):69-75.
Rauch SD, San Martin JE, Moscicki RA, Bloch KJ.
Serum antibodies against heat shock protein 70 in Meniere's
disease.
Am J Otol. 1995 Sep;16(5):648-52.
Shin SO, Billings PB, Keithley EM, Harris JP.
Comparison of anti-heat shock protein 70 (anti-hsp70) and
anti-68-kDa inner ear protein in the sera of patients with
Meniere's disease. Laryngoscope. 1997
Feb;107(2):222-7.
http://www.tchain.com/otoneurology/disorders/autoimmune/otoblot.html
http://www.houseearclinic.com/mjd.htm
http://www.nashvilleent.com/cont_menier.shtml
'Ecstasy'
Callahan BT, Cord BJ, Yuan J, McCann UD, Ricaurte GA.
Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate
methamphetamine-induced dopamine neurotoxicity: possible role of
ionic dysregulation in methamphetamine neurotoxicity.J Neurochem. 2001 Jun;77(5):1348-62.
McCann UD, Eligulashvili V, Ricaurte GA.
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced
serotonin neurotoxicity: clinical studies.
Neuropsychobiology. 2000;42(1):11-6. Review.
Ricaurte GA, Yuan J, McCann UD.
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced
serotonin neurotoxicity: studies in animals.
Neuropsychobiology. 2000;42(1):5-10. Review.Yuan J, Cord BJ, McCann UD, Callahan BT, Ricaurte GA.
Effect of depleting vesicular and cytoplasmic dopamine on
methylenedioxymethamphetamine neurotoxicity. J
Neurochem. 2002 Mar;80(6):960-9.
Hatzidimitriou G, Tsai EH, McCann UD, Ricaurte GA.
Altered prolactin response to M-chlorophenylpiperazine in monkeys
previously treated with 3,4-methylenedioxymethamphetamine (MDMA)
or fenfluramine. Synapse. 2002 Apr;44(1):51-7.
Oxidative stress
Malis CD, Bonventre JV Susceptibility of
mitochondrial membranes to calcium and reactive oxygen species:
implications for ischemic and toxic tissue damage.
Prog Clin Biol Res. 1988;282:235-59. Review.
Thomas CE, Aust SD. Free radicals and
environmental toxins. Ann Emerg Med. 1986
Sep;15(9):1075-83. Review.
Valentine WN, Paglia DE. Syndromes with
increased red cell glutathione (GSH). Hemoglobin.
1980;4(5-6):799-804.
Kondo T. [Impaired glutathione metabolism in
hemolytic anemia] Rinsho Byori. 1990
Apr;38(4):355-9. Review. Japanese.
Spooren AA, Evelo CT. Hydroxylamine treatment
increases glutathione-protein and protein-protein binding in
human erythrocytes. Blood Cells Mol Dis. 1997
Dec;23(3):323-36.
Nitric Oxide
Saenz DA, Cymeryng CB, De Nichilo A, Sacca GB, Keller
Sarmiento MI, Rosenstein RE. Photic regulation of
L-arginine uptake in the golden hamster retina. J
Neurochem. 2002 Feb;80(3):512-9.
Cymeryng CB, Lotito SP, Colonna C, Finkielstein C,
Pomeraniec Y, Grion N, Gadda L, Maloberti P, Podesta EJ.
Expression of nitric oxide synthases in rat adrenal zona
fasciculata cells.
Endocrinology. 2002 Apr;143(4):1235-42.
Cymeryng CB, Lotito SP, Colonna C, Cornejo MF, Podesta
EJ. Induction of nitric oxide synthase activity in
adrenal cells. Endocr Res. 2000 Nov;26(4):589-95.
Cymeryng CB, Dada LA, Colonna C, Mendez CF, Podesta EJ.
Effects of L-arginine in rat adrenal cells: involvement of nitric
oxide synthase. Endocrinology. 1999
Jul;140(7):2962-7.
Cymeryng CB, Dada LA, Podesta EJ. Effect of
nitric oxide on rat adrenal zona fasciculata steroidogenesis. J Endocrinol. 1998 Aug;158(2):197-203.
Mele PG, Dada LA, Paz C, Cymeryng CB, Cornejo Maciel MF,
Neuman MI, Finkielstein CV, Mendez CF, Podesta EJ.
Site of action of proteinases in the activation of
steroidogenesis in rat adrenal gland.
Biochim Biophys Acta. 1996 Feb 29;1310(3):260-8.
Cymeryng CB, Paz C, Dada L, Cornejo Maciel F, Neuman MI,
Mele PG, Finkielstein C, Solano AR, Mendez CF, Park M, et al.
ACTH-dependent proteolytic activity of a novel phosphoprotein
(p43) intermediary in the activation of phospholipase A2 and
steroidogenesis.
Endocr Res. 1995 Feb-May;21(1-2):281-8.
Paz C, Dada LA, Cornejo Maciel MF, Mele PG, Cymeryng CB,
Neuman I, Mendez CF, Finkielstein CV, Solano AR, Park M, et al.
Purification of a novel 43-kDa protein (p43) intermediary in the
activation of steroidogenesis from rat adrenal gland.
Eur J Biochem. 1994 Sep 1;224(2):709-16.
Nitric oxide /Il beta / TNF a
Goodstone NJ, Hardingham TE. Tumour necrosis
factor alpha stimulates nitric oxide production more potently
than interleukin-1beta in porcine articular chondrocytes. Rheumatology (Oxford). 2002 Aug;41(8):883-91.Rediske JJ, Koehne CF, Zhang B, Lotz M. The
inducible production of nitric oxide by articular cell types.
Osteoarthritis Cartilage. 1994 Sep;2(3):199-206.
Zulueta JJ, Sawhney R, Kayyali U, Fogel M, Donaldson C,
Huang H, Lanzillo JJ, Hassoun PM. Modulation of
inducible nitric oxide synthase by hypoxia in pulmonary artery
endothelial cells.
Am J Respir Cell Mol Biol. 2002 Jan;26(1):22-30.
Ribeiro RA, Freitas HC, Campos MC, Santos CC, Figueiredo
FC, Brito GA, Cunha FQ. Tumor necrosis factor-alpha
and interleukin-1beta mediate the production of nitric oxide
involved in the pathogenesis of ifosfamide induced hemorrhagic
cystitis in mice. J Urol. 2002 May;167(5):2229-34.
Schroeder RA, Gu JS, Kuo PC. Interleukin
1beta-stimulated production of nitric oxide in rat hepatocytes is
mediated through endogenous synthesis of interferon gamma. Hepatology. 1998 Mar;27(3):711-9.
Caughey GE, Pouliot M, Cleland LG, James MJ.
Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis
by thromboxane A2 in nonadherent human monocytes.
J Immunol. 1997 Jan 1;158(1):351-8.
Tang X, Zhou D, Kang G. [Induction and
kinetic characterization of nitric oxide synthase in hepatocytes]
Zhonghua Gan Zang Bing Za Zhi. 2001
Jun;9(3):169-71. Chinese.
Kan H, Xie Z, Finkel MS. TNF-alpha enhances
cardiac myocyte NO production through MAP kinase-mediated
NF-kappaB activation. Am J Physiol. 1999 Oct;277(4
Pt 2):H1641-6.
Suzuki N, Sakamoto A, Ogawa R. Effect of
L-canavanine, an Inhibitor of inducible nitric oxide synthase, on
myocardial dysfunction during septic shock. J
Nippon Med Sch. 2002 Feb;69(1):13-8.
Wang Z, Wang M, Carr BI. The inhibitory
effect of interleukin 1beta on rat hepatocyte DNA synthesis is
mediated by nitric oxide. Hepatology. 1998
Aug;28(2):430-5.
Henrotin YE, Zheng SX, Deby GP, Labasse AH, Crielaard
JM, Reginster JY. Nitric oxide downregulates
interleukin 1beta (IL-1beta) stimulated IL-6, IL-8, and
prostaglandin E2 production by human chondrocytes.
J Rheumatol. 1998 Aug;25(8):1595-601.
Morales J, Dunbar JC, Ram JL. Effect of
aldose reductase inhibition on interleukin-1beta-induced nitric
oxide (NO) synthesis in vascular tissue. Int J Exp
Diabetes Res. 2002;3(1):11-20.
Wang CH, Kuo HP. Nitric oxide modulates
interleukin-1beta and tumour necrosis factor-alpha synthesis, and
disease regression by alveolar macrophages in pulmonary
tuberculosis.
Respirology. 2001 Mar;6(1):79-84.
Fukuda K, Kumano F, Takayama M, Saito M, Otani K, Tanaka
S. Zonal differences in nitric oxide synthesis by
bovine chondrocytes exposed to interleukin-1.
Inflamm Res. 1995 Oct;44(10):434-7.
Kanematsu M, Ikeda K, Yamada Y. Interaction
between nitric oxide synthase and cyclooxygenase pathways in
osteoblastic MC3T3-E1 cells. J Bone Miner Res.
1997 Nov;12(11):1789-96.
Eigler A, Sinha B, Endres S. Nitric
oxide-releasing agents enhance cytokine-induced tumor necrosis
factor synthesis in human mononuclear cells.
Biochem Biophys Res Commun. 1993 Oct 15;196(1):494-501.
Gupta RC, Milatovic D, Dettbarn WD. Nitric
oxide modulates high-energy phosphates in brain regions of rats
intoxicated with diisopropylphosphorofluoridate or carbofuran:
prevention by N-tert-butyl-alpha-phenylnitrone or vitamin E. Arch Toxicol. 2001 Aug;75(6):346-56.
Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N,
Nagasaki A, Okabe K. Activated protein C prevents
endotoxin-induced hypotension in rats by inhibiting excessive
production of nitric oxide.
Circulation. 2001 Sep 4;104(10):1171-5.
Immunology (mainly relevant to CFS)
Burrell R. Human immune toxicity. Mol Aspects Med. 1993;14(1):1-81. Review
Dame JB, Chegini N, Christensen RD, Juul SE
The effect of interleukin-1beta (IL-1beta) and tumor necrosis
factor-alpha (TNF-alpha) on granulocyte macrophage-colony
stimulating factor (GM-CSF) production by neuronal precursor
cells. Eur Cytokine Netw. 2002 Jan;13(1):128-33.
Lavie G, Zucker-Franklin D. Cell
surface-associated proteinases in NK cell-mediated cytotoxicity:
enhancement of enzyme expression is unique to activation with
interferon-alpha. Cell Immunol. 1989
Dec;124(2):202-11.
Young JD, Leong LG, Liu CC, Damiano A, Wall DA, Cohn ZA.
Isolation and characterization of a serine esterase from
cytolytic T cell granules. Cell. 1986 Oct
24;47(2):183-94.
Lavie G, Leib Z, Servadio C. The mechanism of
human NK cell-mediated cytotoxicity. Mode of action of
surface-associated proteases in the early stages of the lytic
reaction. J Immunol. 1985 Aug;135(2):1470-6.
Petty HR, Hermann W, Dereski W, Frey T, McConnell HM.
Activatable esterase activity of murine natural killer cell--YAC
tumour cell conjugates. J Cell Sci. 1984
Dec;72:1-13.
Hudig D, Redelman D, Minning LL. The
requirement for proteinase activity for human lymphocyte-mediated
natural cytotoxicity (NK): evidence that the proteinase is serine
dependent and has aromatic amino acid specificity of cleavage. J Immunol. 1984 Nov;133(5):2647-54.
Zucker-Franklin D, Yang J, Fuks A. Different
enzyme classes associated with human natural killer cells may
mediate disparate functions. J Immunol. 1984
Mar;132(3):1451-5.
Dioxins and PCBs
Schantz SL, Widholm JJ, Rice DC.Effects of
PCB exposure on neuropsychological function in children.
Environ Health Perspect. 2003 Mar;111(3):357-576.
Review.
Shon YH, Park IK, Moon IS, Chang HW, Park IK, Nam KS.
Effect of chitosan oligosaccharide on
2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in
mice. Biol Pharm Bull. 2002 Sep;25(9):1161-4.
Vreugdenhil HJ, Slijper FM, Mulder PG, Weisglas-Kuperus
N. Effects of Perinatal Exposure to PCBs and Dioxins
on Play Behavior in Dutch Children at School Age.
Environ Health Perspect. 2002 Oct;110(10):A593-8.
Rinaldi AL, Morse MA, Fields HW, Rothas DA, Pei P,
Rodrigo KA, Renner RJ, Mallery SR. Curcumin activates
the aryl hydrocarbon receptor yet significantly inhibits
(-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral
squamous cell carcinoma cells and oral mucosa.
Cancer Res. 2002 Oct 1;62(19):5451-6.
Latchoumycandane C, Mathur PP. Effects of
vitamin E on reactive oxygen species-mediated
2,3,7,8-tetrachlorodi-benzo-p-dioxin toxicity in rat testis. J Appl Toxicol. 2002 Sep-Oct;22(5):345-51.
Aplastic anaemia, anaemia /pesticides
Reeves JD. Household insecticide-associated
blood dyscrasias in children. Am J Pediatr Hematol
Oncol. 1982 Winter;4(4):438-9. No abstract available.
Reeves JD, Driggers DA, Kiley VA. Household
insecticide associated aplastic anaemia and acute leukaemia in
children.
Lancet. 1981 Aug 8;2(8241):300-1. No abstract
available.
Infra sound
http://www.umea.irf.se/ume/
Concorde
Spreng M.[Specific features of military
low-altitude flight noise: criteria for risk of damage and
physiological effects. Schriftenr Ver Wasser Boden
Lufthyg. 1993;88:271-87. Review.
Gomes LM, Martinho Pimenta AJ, Castelo Branco NA.Effects
of occupational exposure to low frequency noise on cognition. Aviat Space Environ Med. 1999 Mar;70(3 Pt 2):A115-8.
Sova SH. [Peripheral autonomic insufficiency
in workers who sustain the chronic effect of an occupational
vibration-noise factor] Lik Sprava. 1999
Jun;(4):165-8. Ukrainian.
Gordeladze AS, Glinchikov VV, Usenko VR.
[Experimental myocardial ischemia caused by infrasound]
Gig Tr Prof Zabol. 1986 Jun;(6):30-3. Russian. No
abstract available.
Shvaiko II, Koairin IP, Mikhaliuk IA, Motuzkov IN.
[Effect of infrasound on the metabolism of microelements in the
body] Gig Sanit. 1984 Sep;(9):91-2. Russian. No
abstract available.
Nekhoroshev AS. [Study of mechanisms
underlying the effects of low-frequency acoustic vibrations]
Med Tr Prom Ekol. 1998;(5):26-30. Russian.
Syromiatnikov IuP. [Evaluation of preclinical
signs due to exposure of workers to static magnetic fields]
Gig Sanit. 1998 Jan-Feb;(1):14-5. Russian. No
abstract available.
Nekhoroshev AS, Glinchikov VV. [Morphological
research on the liver structures of experimental animals under
the action of infrasound] Aviakosm Ekolog Med.
1992 May-Jun;26(3):56-9. Russian.
Krivolesova SA, Svidovyi VI, Lobov GI, Dadali VA.
[Effects of infrasound and noise on contractility of lymphatic
vessels (an experimental study)] Med Tr Prom Ekol.
2001;(2):16-20. Russian.
Svidovyi VI. [Mechanism of perception and
effect of infrasound on the bodies of experimental animals and
man] Gig Sanit. 1987 Mar;(3):88-9. Russian. No
abstract available.
Svidovyi VI, Kitaeva LV. [Evaluation of
cytogenetic activity in bone marrow cells exposed to infrasound
(experimental data)] Med Tr Prom Ekol.
1998;(5):42-4. Russian. No abstract available.
Kuralesin NA. [Hygienic and biomedical
aspects of the effects of infrasound]
Med Tr Prom Ekol. 1997;(5):8-14. Russian.
Balunov VD, Barsukov AF, Artamonova VG.
[Clinical and functional evaluation of health status of workers
exposed to infrasound, noise and general vibration]
Med Tr Prom Ekol. 1998;(5):22-6. Russian.
Batanov GV. [Characteristics of etiology of
immediate hypersensitivity in conditions of exposure to
infrasound]
Radiats Biol Radioecol. 1995 Jan-Feb;35(1):78-82.
Russian.
Izmerov NF, Suvorov GA, Kuralesin NA, Ovakimov VG.
[Infrasound: body's effects and hygienic regulation]
Vestn Ross Akad Med Nauk. 1997;(7):39-46. Review.
Russian.
Pawlaczyk-Luszczynska M. Infrasound in the
occupational and general environment: a three-element microphone
measuring method for locating distant sources of infrasound. Int J Occup Med Environ Health. 1996;9(1):17-27.
Bento Coelho JL, Ferreira A, Serrano J, Castelo Branco
NA. Noise assessment during aircraft run-up
procedures. Aviat Space Environ Med. 1999 Mar;70(3
Pt 2):A22-6.
Harris CS, Sommer HC, Johnson DL. Review of
the effects of infrasound on man. Aviat Space
Environ Med. 1976 Apr;47(4):430-4. Bento Coelho JL, Ferreira A, Serrano J, Castelo Branco
NA. Noise assessment during aircraft run-up
procedures.
Aviat Space Environ Med. 1999 Mar;70(3 Pt
2):A22-6.
Castelo Branco NA, Rodriguez E. The
vibroacoustic disease--an emerging pathology.
Aviat Space Environ Med. 1999 Mar;70(3 Pt 2):A1-6.
Review.
Silva MJ, Carothers A, Castelo Branco NA, Dias A,
Boavida MG. Sister chromatid exchange analysis in
workers exposed to noise and vibration. Aviat
Space Environ Med. 1999 Mar;70(3 Pt 2):A40-5.
Castro AP, Aguas AP, Grande NR, Monteiro E, Castelo
Branco NA. Increase in CD8+ and CD4+ T lymphocytes in
patients with vibroacoustic disease. Aviat Space
Environ Med. 1999 Mar;70(3 Pt 2):A141-4.
Alves-Pereira M. Noise-induced extra-aural
pathology: a review and commentary.
Aviat Space Environ Med. 1999 Mar;70(3 Pt
2):A7-21. Review.
Castelo Branco NA, Rodriguez E, Alves-Pereira M, Jones
DR. Vibroacoustic disease: some forensic aspects.
Aviat Space Environ Med. 1999 Mar;70(3 Pt
2):A145-51.
Castelo Branco NA. The clinical stages of
vibroacoustic disease. Aviat Space Environ Med.
1999 Mar;70(3 Pt 2):A32-9.
Castelo Branco NA. A unique case of
vibroacoustic disease: a tribute to an extraordinary patient.
Aviat Space Environ Med. 1999 Mar;70(3 Pt
2):A27-31.
Marciniak W, Rodriguez E, Olszowska K, Atkov O, Botvin
I, Araujo A, Pais F, Soares Ribeiro C, Bordalo A, Loureiro J,
Prazeres De Sa E, Ferreira D, Castelo Branco MS, Castelo Branco
NA Echocardiographic evaluation in 485 aeronautical
workers exposed to different noise environments.
Aviat Space Environ Med. 1999 Mar;70(3 Pt
2):A46-53.
Takahashi Y, Yonekawa Y, Kanada K. A new
approach to assess low frequency noise in the working
environment. Ind Health. 2001 Jul;39(3):281-6.
Multiple sclerosis
Vojdani A, Vojdani E, Cooper E. Antibodies to
myelin basic protein, myelin oligodendrocytes peptides,
alpha-beta-crystallin, lymphocyte activation and cytokine
production in patients with multiple sclerosis.
J Intern Med. 2003 Oct;254(4):363-74.
Purdey M. Chronic barium intoxication
disrupts sulphated proteoglycan synthesis: a hypothesis for the
origins of multiple sclerosis. Med Hypotheses.
2004;62(5):746-54.
Hoffman RE, Zack MM, Davis LE, Burchfiel CM.
Increased incidence and prevalence of multiple sclerosis in Los
Alamos County, New Mexico. Neurology. 1981
Nov;31(11):1489-92.
Schiffer RB, Weitkamp LR, Ford C, Hall WJ. A
genetic marker and family history study of the upstate New York
multiple sclerosis cluster. Neurology. 1994
Feb;44(2):329-3.
Potemkowski A. [An
epidemiologic survey of multiple sclerosis in the Szczecin
province in Poland.]
Przegl Epidemiol. 2001;55(3):331-41. Polish.
Schiffer RB, McDermott MP, Copley C. A
multiple sclerosis cluster associated with a small, north-central
Illinois community. Arch Environ Health. 2001
Sep-Oct;56(5):389-95.
Hopkins RS, Indian RW, Pinnow E, Conomy J Multiple sclerosis in Galion, Ohio: prevalence
and results of a case-control study.Neuroepidemiology.
1991;10(4):192-9.
Kurtzke JF, Heltberg A. Multiple sclerosis in
the Faroe Islands: an epitome. J Clin Epidemiol.
2001 Jan;54(1):1-22.
Poskanzer DC, Walker AM, Prenney LB, Sheridan JL.The
etiology of multiple sclerosis: temporal-spatial clustering
indicating two environmental exposures before onset. Neurology. 1981 Jun;31(6):708-13.
Flodin U, Landtblom AM, Axelson O. Multiple sclerosis in nurse anaesthetists. Occup Environ Med. 2003 Jan;60(1):66-8.
Riise T, Gronning M, Klauber MR, Barrett-Connor E,
Nyland H, Albrektsen G. Clustering of residence of
multiple sclerosis patients at age 13 to 20 years in Hordaland,
Norway. Am J Epidemiol. 1991 May 1;133(9):932-9. Berr C, Puel J, Clanet M, Ruidavets JB, Mas JL,
Alperovitch A. Risk factors in multiple sclerosis: a
population-based case-control study in Hautes-Pyrenees, France.
Acta Neurol Scand. 1989 Jul;80(1):46-50.
Brosseau L, Philippe P, Methot G, Duquette P, Haraoui B.
Drug abuse as a risk factor of multiple sclerosis: case-control
analysis and a study of heterogeneity.
Neuroepidemiology. 1993;12(1):6-14.
Stein EC, Schiffer RB, Hall WJ, Young N
Multiple sclerosis and the workplace: report of an industry-based
cluster.
Neurology. 1987 Oct;37(10):1672-7.
Flodin U, Soderfeldt B, Noorlind-Brage H, Fredriksson M,
Axelson O. Multiple sclerosis, solvents, and pets. A
case-referent study. Arch Neurol. 1988
Jun;45(6):620-3.
Krebs JM, Park RM, Boal WL.A neurological
disease cluster at a manufacturing plant. Arch
Environ Health. 1995 May-Jun;50(3):190-5.
Asbestos/mineral, vitreous fibre
Tan RJ, Fattman CL, Watkins SC, Oury TD.Redistribution
of pulmonary EC-SOD after exposure to asbestos.
J Appl Physiol. 2004 Aug 6 [Epub ahead of print]
Cavallo D, Campopiano A, Cardinali G, Casciardi S,
Simone PD, Kovacs D, Perniconi B, Spagnoli G, Ursini CL, Fanizza
C. Cytotoxic and oxidative effects induced by man-made
vitreous fibers (MMVFs) in a human mesothelial cell line. Toxicology. 2004 Sep 1;201(1-3):219-29.
Tulinska J, Jahnova E, Dusinska M, Kuricova M, Liskova
A, Ilavska S, Horvathova M, Wsolova L, Kyrtopoulos SA, Collins A,
Harrington V, Fuortes L. Immunomodulatory
effects of mineral fibres in occupationally exposed workers. Mutat Res. 2004 Sep 3;553(1-2):111-24.
Dusinska M, Collins A, Kazimirova A, Barancokova M,
Harrington V, Volkovova K, Staruchova M, Horska A, Wsolova L,
Kocan A, Petrik J, Machata M, Ratcliffe B, Kyrtopoulos S.
Genotoxic effects of asbestos in humans.
Mutat Res. 2004 Sep 3;553(1-2):91-102.